This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
Read twice and referred to the Committee on Finance.
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)
Referred to the Subcommittee on Health.
Received in the Senate and Read twice and referred to the Committee on Finance.
Introduced in Senate
Read twice and referred to the Committee on Finance.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line